As of 2025-05-11, the Fair Value of US Stem Cell Inc (USRM) is -0.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of US Stem Cell Inc is -11,237.60%.
With the market price of 0.00 USD and our fair value calculation, US Stem Cell Inc (USRM) is not a good investment. Investing in USRM stocks now will result in a potential loss of 11,237.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -2.16 | -3.84 | -2.89 | -3.29 | -2.86 | -3.01 |
| YoY growth | 37.95% | -77.53% | 24.64% | -13.73% | 13.06% | -3.12% |
| Market Cap (mil) | 0.13 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -3.12% |
| TTM earnings | -2.86 |